Paper Details

  1. Home
  2. Paper Details

Antiviral therapy of hepatitis C.

Author: BrouwerJ T, SchalmS W

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Interferon mono-therapy leads to viral clearance in only 10% of patients with genotype 1 and in less than 10% in cirrhosis. Interferon-ribavirin combination therapy appears to enhance the efficacy 2-3 fold without increasing toxicity.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Chronic hepatitis C can be treated with interferon therapy, but persistent viral clearance is only achieved in 20% of patients. Which patients have a high chance of viral clearance and what other treatment might enhance the effectivity of interferon therapy are reviewed. METHODS: Data f...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/9200306

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Hepatitis C: A Quest for Effective Treatment

Hepatitis C, a chronic liver infection, can lead to serious complications. This research delves into the complex world of hepatitis C treatment, exploring the efficacy of interferon therapy and the potential for combination therapies to improve outcomes. It's like traversing a vast desert landscape, seeking a path to cure and a way to alleviate the burden of this debilitating disease.

Finding a Path to Cure: Interferon Therapy and Combination Therapies

The study highlights the limitations of interferon monotherapy, emphasizing the need for more effective treatment options. It explores the potential of combination therapies, such as interferon-ribavirin and interferon-ursodeoxycholic acid, to enhance viral clearance rates. This is like seeking a more efficient route through the desert, finding a combination of strategies that can overcome the challenges of hepatitis C. The study underscores the importance of continued research in the field of hepatitis C treatment, seeking to optimize treatment strategies and improve patient outcomes.

A Glimmer of Hope in the Desert

The findings of this study offer a glimmer of hope for patients battling hepatitis C, providing valuable insights into the potential for more effective treatment strategies. It is like finding a hidden spring of healing in the desert, offering renewed optimism and a path toward a healthier future. This research highlights the importance of continued innovation in the development of new treatments for viral infections, seeking to alleviate suffering and improve the lives of those affected.

Dr. Camel's Conclusion

This research serves as a reminder that the fight against hepatitis C is an ongoing journey. It's a journey through a vast and challenging desert landscape, requiring persistence, innovation, and a commitment to finding a cure. As we continue to explore new frontiers in medicine, we must remain optimistic, seeking to provide hope and healing to those affected by this debilitating disease.

Date :
  1. Date Completed 1997-08-06
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

9200306

DOI: Digital Object Identifier

9200306

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.